In this episode, we discuss why regulating PBMs’ rebate practices will not shift rebate benefits from PBMs to payers or consumers, nor will it bend the cost curve. On the contrary, prohibiting rebates or fees linked to list prices and volume would increase prescription drug spending. See below why that is the case.

00:00 Introduction

03:03 What does a PBM do?

04:15 How do PBMs make money?

05:39 How much value do PBMs generate for the society?

06:55 Why regulating PBM rebate practices will not work?

11:06 What can we do to address the public's concerns then?

13:35 Summary

We strive to translate scientific findings into plain language to answer challenging healthcare questions of our time. Our unique perspectives and insights are hard to find from other venues.

You can find our articles here: https://hotbutton.substack.com

Let us know the topics of your interest. We would love to cover them. Thank you!

The video is provided by Analytica Now, a company specializing in health analytics, economics, and policy. https://analyticanow.net

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit hotbutton.substack.com